Wild-type (senile) amyloidosis surgery: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 7: | Line 7: | ||
==Surgery== | ==Surgery== | ||
*Surgery is not the mainstay of therapy for wild-type (senile) amyloidosis. | *Surgery is not the mainstay of therapy for wild-type (senile) amyloidosis. | ||
*Left ventricular assist devices (LVAD) implantation can be considered but a review of the Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) database is necessary to better evaluate the outcomes of LVAD implantation. | *Left ventricular assist devices (LVAD) implantation can be considered but a review of the Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) database is necessary to better evaluate the outcomes of LVAD implantation in these patients.<ref>{{Cite journal | ||
| author = [[Paul L. Swiecicki]], [[Brooks S. Edwards]], [[Sudhir S. Kushwaha]], [[Angela Dispenzieri]], [[Soon J. Park]] & [[Morie A. Gertz]] | |||
| title = Left ventricular device implantation for advanced cardiac amyloidosis | |||
| journal = [[The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation]] | |||
| volume = 32 | |||
| issue = 5 | |||
| pages = 563–568 | |||
| year = 2013 | |||
| month = May | |||
| doi = 10.1016/j.healun.2013.01.987 | |||
| pmid = 23474361 | |||
}}</ref> | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
Revision as of 20:13, 19 December 2019
|
Wild-type (senile) amyloidosis Microchapters |
|
Differentiating Wild-type (senile) amyloidosis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Wild-type (senile) amyloidosis surgery On the Web |
|
American Roentgen Ray Society Images of Wild-type (senile) amyloidosis surgery |
|
Risk calculators and risk factors for Wild-type (senile) amyloidosis surgery |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Surgery
- Surgery is not the mainstay of therapy for wild-type (senile) amyloidosis.
- Left ventricular assist devices (LVAD) implantation can be considered but a review of the Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) database is necessary to better evaluate the outcomes of LVAD implantation in these patients.[1]
References
- ↑ Paul L. Swiecicki, Brooks S. Edwards, Sudhir S. Kushwaha, Angela Dispenzieri, Soon J. Park & Morie A. Gertz (2013). "Left ventricular device implantation for advanced cardiac amyloidosis". The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 32 (5): 563–568. doi:10.1016/j.healun.2013.01.987. PMID 23474361. Unknown parameter
|month=ignored (help)